RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,449,568 | +2.4% | 5,941,120 | 0.0% | 43.00% | +30.9% |
| Q2 2023 | $44,380,166 | +12.0% | 5,941,120 | 0.0% | 32.86% | -22.2% |
| Q1 2023 | $39,627,270 | -13.5% | 5,941,120 | 0.0% | 42.23% | -12.2% |
| Q4 2022 | $45,806,035 | -27.5% | 5,941,120 | 0.0% | 48.11% | -3.7% |
| Q3 2022 | $63,214,000 | +30.7% | 5,941,120 | 0.0% | 49.97% | +25.1% |
| Q2 2022 | $48,361,000 | +13.7% | 5,941,120 | 0.0% | 39.94% | +342.4% |
| Q1 2022 | $42,538,000 | -58.2% | 5,941,120 | 0.0% | 9.03% | -34.3% |
| Q4 2021 | $101,771,000 | – | 5,941,120 | – | 13.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $16,889,000 | 37.30% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $31,958,000 | 5.87% |
| Yong Rong (HK) Asset Management Ltd | 377,000 | $8,675,000 | 5.69% |
| Samsara BioCapital, LLC | 752,939 | $17,325,000 | 2.72% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $34,728,000 | 2.04% |
| Spouting Rock Asset Management, LLC | 52,851 | $1,216,000 | 0.61% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 661,703 | $15,226,000 | 0.43% |
| Laurion Capital Management LP | 3,923,713 | $90,285,000 | 0.38% |
| Casdin Capital, LLC | 548,156 | $12,613,000 | 0.31% |
| Baillie Gifford | 22,061,374 | $507,632,000 | 0.27% |